Maximizing Drug Patents’ Value: Strategies for Biomedical Companies
The article “Maximizing the Value of Drug Patents Before Losing Exclusivity” discusses strategies for biomedical companies to maximize the value of their drug patents before the exclusivity period expires. In the world of medical and biotechnology companies, losing exclusivity on a drug patent doesn’t have to mean the end of profits. When a new drug […] Source